Pulse Oximetry Screening definition

Pulse Oximetry Screening means a test using a device placed on an extremity to measure the percentage of oxygen in the blood.
Sample 1Sample 2Sample 3
Pulse Oximetry Screening means a test using a device placed
Sample 1Sample 2

Examples of Pulse Oximetry Screening in a sentence

  • Screening for critical congenital heart disease using pulse oximetry should be performed in newborns, after 24 hours of age, before discharge from the hospital, per the 2011 AAP statement “Endorsement of Health and Human Services Recommendation for Pulse Oximetry Screening for Critical Congenital Heart Disease” ( http://pediatrics.aappublications.org/content/129/1/190.full).

  • Perfusion Index and Pulse Oximetry Screening for Congenital Heart Defects.

  • Widder KJ, Morris RM, Poore G, Howard DP Jr, Senyei AE (1981) Tumor remission in Yoshida sarcoma- bearing rts by selective targeting of magnetic albumin microspheres con- taining doxorubicin.

  • Specimens should be transported in the manner designated by the Department.(b) Pulse Oximetry Screening Results.(1) Recordation of Results.

  • Newborn Pulse Oximetry Screening Brochures can be ordered from the OSDH NBS Program by faxing the appropriate Supply Order Form for brochures to 405-271-4892.

  • Also the reference to Appendix D, Recommended Pulse Oximetry Screening Protocol, was removed as that document will now be publically available on the OSDH website.310:550-7-1 - The proposal replace the term “collection” with the term “form” for clarity and consistency when referring to the newborn screening from kit.

  • Appendix Michigan Algorithm for Pulse Oximetry Screening MDHHS-Pub-1458 (Rev.

  • Filed with the Office of the Secretary of State on October 18, 2019.TRD-201903792Catherine Reyer General CounselTexas Department of BankingEarliest possible date of adoption: December 1, 2019 For further information, please call: (512) 475-1301♦ ♦ ♦SUBCHAPTER E.

  • The area of FZ3b on the upper reaches of the Mardyke has significantly reduced.The Beam, Ingrebourne and Ravensbourne extents are relatively unchanged.

  • Dba GM Financial Represented By William Edward CraigAttorney: Michael J.

Related to Pulse Oximetry Screening

  • Fluoroscopic imaging assembly means a subsystem in which X-ray photons produce a visual image. It includes the image receptor(s) such as the image intensifier and spot-film device, electrical interlocks, if any, and structural material providing linkage between the image receptor and diagnostic source assembly.

  • Assay means a laboratory analysis of Crude Petroleum to include the following: A.P.I. Gravity, Reid vapor pressure, composition, pour point, water and sediment content, sulfur content, viscosity, distillation, hydrogen sulfide, flash/boiling point and other characteristics as may be required by Carrier.

  • Screening means the evaluation process used to identify an individual's ability to perform activities of daily living and address health and safety concerns.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • HIV means human immunodeficiency virus.

  • Sampler means a person who is employed by or is an owner of a licensed laboratory, grower, or processor and is authorized by that employer to collect samples in accordance with the testing laboratory's standard operating procedures and these Rules.

  • Prosthesis means an artificial substitute for a missing body part.

  • Aerosol coating product means a pressurized coating product containing pigments or resins that dispenses product ingredients by means of a propellant, and is packaged in a disposable can for hand-held application, or for use in specialized equipment for ground traffic/marking applications.

  • COVID-19 symptoms means fever of 100.4 degrees Fahrenheit or higher, chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, or diarrhea, unless a licensed health care professional determines the person’s symptoms were caused by a known condition other than COVID-19.

  • Diagnostic mammography means a method of screening that

  • Nitrogen oxides means nitric oxide and nitrogen dioxide, expressed as nitrogen dioxide (NO2);

  • Diatomaceous earth filtration means a process resulting in substantial particulate removal in which a precoat cake of diatomaceous earth filter media is deposited on a support membrane (septum), and while the water is filtered by passing through the cake on the septum, additional filter media known as body feed is continuously added to the feed water to maintain the permeability of the filter cake.

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Grab sample means an individual sample collected in less than 15 minutes in conjunction with an instantaneous flow measurement.

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • Cannabinoid extract means a substance obtained by separating cannabinoids from marijuana by:

  • Analytical x-ray system means a group of components utilizing x-rays to determine the elemental composition or to examine the microstructure of materials.